THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS
AboElkheir, H., Deghady, A., ElDeeb, R., Sallam, E. (2023). THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS. EKB Journal Management System, 5(3), 29-30. doi: 10.21608/alexpo.2023.229006.1669
HossamEl-Dein AboElkheir; Akram Abdel Moneim Deghady; Rabab ElDeeb; Eman Gamal Sallam. "THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS". EKB Journal Management System, 5, 3, 2023, 29-30. doi: 10.21608/alexpo.2023.229006.1669
AboElkheir, H., Deghady, A., ElDeeb, R., Sallam, E. (2023). 'THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS', EKB Journal Management System, 5(3), pp. 29-30. doi: 10.21608/alexpo.2023.229006.1669
AboElkheir, H., Deghady, A., ElDeeb, R., Sallam, E. THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS. EKB Journal Management System, 2023; 5(3): 29-30. doi: 10.21608/alexpo.2023.229006.1669

THE RELATION BETWEEN INTESTINAL FATTY ACIDS BINDING PROTEIN-2 AND CHRONIC USE OF PROTON PUMP INHIBITORS IN DECOMPENSATED CIRRHOSIS

ALEXMED ePosters
Article 1, Volume 5, Issue 3, September 2023, Page 29-30  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.229006.1669
View on SCiNiTO View on SCiNiTO
Authors
HossamEl-Dein AboElkheir1; Akram Abdel Moneim Deghady2; Rabab ElDeeb1; Eman Gamal Sallam email 1
1Tropical Medicine Department, Faculty of Medicine, Alexandria University.
2Department of Clinical and Chemical Pathology, University of Alexandria
Abstract
Liver cirrhosis is a global issue that affects people of all ages, genders, and ethnicities, In the world, it is the 14th most prevalent cause of mortality in adults , ranking 4th in Europe and 9th in theUnited States.
The connections between the gut and liver have given rise to the phrase "gut-liver axis."Thisaxis could be disturbed in decompensated cirrhosis with increase intestinal permeability.
Recent research has identified medications use as one of the most significant contributors to the disruption of the composition of the gut microbiota and gut- liver axis failure. Example of these medications includes proton pump inhibitors (PPIs).
Aim of the work:
The aim of the study was to measure IFABP2 as a diagnostic marker for gut wall integrity in decompensated cirrhosis.Moreover, its relationship with chronic use of PPIs in cirrhosis.
Patients and Methods:
This study was carried out on 75 candidates (32 females & 43 males) at Tropical medicine Department of Alexandria university. Subjects were categorized into 3 groups; group I (n=30) with compensated liver cirrhosis, group II (n=30) with hepatic decompensation which were subdivided into Group IIa (n=15) with chronic use of PPIs and Group IIb(n=15) without chronic use of PPIs, and group III (n=15) healthy controls.IFABP2was measured by ELISA.
Keywords
PPIs; IFABP2; gut- liver axis
Supplementary Files
Statistics
Article View: 83